Fundraising FoxActive Genomes Expressed Diagnostics
Washington, US · Founded 2021 · District of Columbia corporation
Find your way into Active Genomes Expressed Diagnostics
Sign up to see every warm intro you have to Active Genomes Expressed Diagnostics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Active Genomes Expressed Diagnostics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
RZ
Rachel ZayasNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$250K disclosed across 1 round · 2022
▶$250KraisedFeb 2023 · 2 investors · Other TechnologyRule 506(b)
▶$250KraisedFeb 2023 · 2 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Rachel ZayasExecutive Officer, Director
- Offering amount
- $1.8M
- Amount sold
- $250K
- Minimum investment
- $100K
- First sale
- Dec 2022
- Incorporated
- Corporation, District Of Columbia, 2021
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Active Genomes Expressed Diagnostics raised?
- Active Genomes Expressed Diagnostics has disclosed $250K raised across 1 round.
- Where is Active Genomes Expressed Diagnostics headquartered?
- Active Genomes Expressed Diagnostics is headquartered in Washington, US.